These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16971054)

  • 1. Cost-effectiveness of prize-based incentives for stimulant abusers in outpatient psychosocial treatment programs.
    Olmstead TA; Sindelar JL; Petry NM
    Drug Alcohol Depend; 2007 Mar; 87(2-3):175-82. PubMed ID: 16971054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of prize-based contingency management in methadone maintenance treatment programs.
    Sindelar JL; Olmstead TA; Peirce JM
    Addiction; 2007 Sep; 102(9):1463-71. PubMed ID: 17645428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost-effectiveness of prize-based and voucher-based contingency management in a population of cocaine- or opioid-dependent outpatients.
    Olmstead TA; Petry NM
    Drug Alcohol Depend; 2009 Jun; 102(1-3):108-15. PubMed ID: 19324501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motivational incentives research in the National Drug Abuse Treatment Clinical Trials Network.
    Stitzer ML; Petry NM; Peirce J
    J Subst Abuse Treat; 2010 Jun; 38 Suppl 1(Suppl 1):S61-9. PubMed ID: 20307797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs and effectiveness of substance abuse treatments for homeless persons.
    Schumacher JE; Mennemeyer ST; Milby JB; Wallace D; Nolan K
    J Ment Health Policy Econ; 2002 Mar; 5(1):33-42. PubMed ID: 12529568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contingency Management Abstinence Incentives: Cost and Implications for Treatment Tailoring.
    Cunningham C; Stitzer M; Campbell AN; Pavlicova M; Hu MC; Nunes EV
    J Subst Abuse Treat; 2017 Jan; 72():134-139. PubMed ID: 26482136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Criminal justice referral and incentives in outpatient substance abuse treatment.
    DeFulio A; Stitzer M; Roll J; Petry N; Nuzzo P; Schwartz RP; Stabile P
    J Subst Abuse Treat; 2013 Jul; 45(1):70-5. PubMed ID: 23433822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinic variation in the cost-effectiveness of contingency management.
    Olmstead TA; Sindelar JL; Petry NM
    Am J Addict; 2007; 16(6):457-60. PubMed ID: 18058410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness of four treatments for marijuana dependence.
    Olmstead TA; Sindelar JL; Easton CJ; Carroll KM
    Addiction; 2007 Sep; 102(9):1443-53. PubMed ID: 17645430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of motivational incentives in stimulant abusing outpatients with different treatment histories.
    Killeen T; Carter R; Copersino M; Petry N; Stitzer M
    Am J Drug Alcohol Abuse; 2007; 33(1):129-37. PubMed ID: 17366253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs and cost-effectiveness of adolescent compliance with treatment for latent tuberculosis infection: results from a randomized trial.
    Kominski GF; Varon SF; Morisky DE; Malotte CK; Ebin VJ; Coly A; Chiao C
    J Adolesc Health; 2007 Jan; 40(1):61-8. PubMed ID: 17185207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-cost contingency management in community clinics: delivering incentives partially in group therapy.
    Alessi SM; Hanson T; Wieners M; Petry NM
    Exp Clin Psychopharmacol; 2007 Jun; 15(3):293-300. PubMed ID: 17563216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of Internet-based problem-solving guided self-help treatment in comparison with enhanced usual care for depressed outpatients waiting for face-to-face treatment: A randomized controlled trial.
    Kolovos S; Kenter RM; Bosmans JE; Beekman AT; Cuijpers P; Kok RN; van Straten A
    J Affect Disord; 2016 Aug; 200():284-92. PubMed ID: 27155071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and cost-effectiveness of four treatment modalities for substance disorders: a propensity score analysis.
    Mojtabai R; Zivin JG
    Health Serv Res; 2003 Feb; 38(1 Pt 1):233-59. PubMed ID: 12650390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What do we get for our money? Cost-effectiveness of adding contingency management.
    Sindelar J; Elbel B; Petry NM
    Addiction; 2007 Feb; 102(2):309-16. PubMed ID: 17222286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: the CIRCLE RCT.
    Johnson S; Rains LS; Marwaha S; Strang J; Craig T; Weaver T; McCrone P; King M; Fowler D; Pilling S; Marston L; Omar RZ; Craig M; Spencer J; Hinton M
    Health Technol Assess; 2019 Aug; 23(45):1-108. PubMed ID: 31460865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An implementation-focused process evaluation of an incentive intervention effectiveness trial in substance use disorders clinics at two Veterans Health Administration medical centers.
    Hagedorn HJ; Stetler CB; Bangerter A; Noorbaloochi S; Stitzer ML; Kivlahan D
    Addict Sci Clin Pract; 2014 Jul; 9(1):12. PubMed ID: 25008457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.